SCHEMBL28912968

SCHEMBL28912968

CC(C)c1nccc(C(F)F)c1N

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.33
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29491137 0.86 NOS3 (0.35) TDO2NOS3NOS2HRH4
SCHEMBL9777733 0.86 NOS3 (0.35) TDO2NOS3NOS2HRH4
SCHEMBL25665327 0.81 NOS3 (0.32) NOS3NOS2
SCHEMBL29663648 0.81 NOS3 (0.32) NOS3NOS2
SCHEMBL24246883 0.78 KRAS (0.35) TDO2
SCHEMBL29778866 0.76 NOS3 (0.39) NOS3NOS2
SCHEMBL23131810 0.76 NOS3 (0.34) NOS3NOS2
SCHEMBL22836874 0.76 NOS3 (0.34) TDO2NOS3NOS2
SCHEMBL23326008 0.76 NOS3 (0.39) NOS3NOS2
SCHEMBL31569347 0.75 NOS2 (0.46) NOS3NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574199-B Heterocyclic compounds as Kras-G12C inhibitors 首药控股(北京)股份有限公司 2021-05-18 CN disclosed
CN-112574199-A Heterocyclic compounds as Kras-G12C inhibitors 首药控股(北京)股份有限公司 2021-03-30 CN disclosed